{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:08:43Z","timestamp":1794848923488,"version":"4.9.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01 DK111715"],"award-info":[{"award-number":["K01 DK111715"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK19525"],"award-info":[{"award-number":["P30 DK19525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.jcmgh.2018.10.016","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T12:21:39Z","timestamp":1541247699000},"page":"447-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":308,"title":["Resolving the Paradox of Hepatic Insulin Resistance"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4468-6564","authenticated-orcid":false,"given":"Dominic","family":"Santoleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Titchenell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2018.10.016_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.jcmgh.2018.10.016_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1463-1326.2011.01454.x","article-title":"Physiologic action of glucagon on liver glucose metabolism","volume":"13","author":"Ramnanan","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2011.06.003","article-title":"Hormonal regulation of hepatic glucose production in health and disease","volume":"14","author":"Lin","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0168-8278(98)80073-1","article-title":"Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance","volume":"29","author":"James","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib9","first-page":"701","article-title":"Effects of free fatty acid elevation on and gluconeogenesis in humans","volume":"49","author":"Roden","year":"2000","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","article-title":"Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis","volume":"7","author":"Biddinger","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cmet.2012.05.002","article-title":"Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression","volume":"15","author":"Haas","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib13","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","article-title":"Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction","volume":"6","author":"Michael","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib15","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db16-0213","article-title":"Lipodystrophy due to adipose tissue-specific insulin receptor knockout results in progressive NAFLD","volume":"65","author":"Softic","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib16","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1038\/ncomms8078","article-title":"Hepatic insulin signaling is dispensible for suppression of glucose output by insulin in\u00a0vivo","volume":"6","author":"Titchenell","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2008.06.006","article-title":"Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation","volume":"8","author":"Dong","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib20","doi-asserted-by":"crossref","first-page":"12977","DOI":"10.1038\/ncomms12977","article-title":"Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity","volume":"7","author":"Kubota","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib21","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1172\/JCI0215880","article-title":"Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver","volume":"110","author":"Miyake","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmet.2006.04.005","article-title":"Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKC\u03bb\/\u03b6","volume":"3","author":"Taniguchi","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2337\/db10-0869","article-title":"Ablation of PI3K p110-\u03b1 prevents high-fat diet-induced liver steatosis","volume":"60","author":"Chattopadhyay","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1042\/BJ20041782","article-title":"Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure","volume":"385","author":"Mora","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib25","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI20513","article-title":"Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas","volume":"113","author":"Horie","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib26","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.2353\/ajpath.2010.090931","article-title":"The critical role of AKT2 in hepatic steatosis induced by PTEN loss","volume":"176","author":"He","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib27","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and Regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI16885","article-title":"Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2\/PKB\u03b2","volume":"112","author":"Garofalo","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib29","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","article-title":"Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBbeta)","volume":"292","author":"Cho","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2009.10.004","article-title":"Akt2 is required for hepatic lipid accumulation in models of insulin resistance","volume":"10","author":"Leavens","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nm.2686","article-title":"Insulin regulates liver metabolism in\u00a0vivo in the absence of hepatic Akt and Foxo1","volume":"18","author":"Lu","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib32","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cmet.2016.04.022","article-title":"Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production","volume":"23","author":"Titchenell","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib33","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.cell.2013.11.049","article-title":"Spatial control of the TSC complex integrates insulin and nutrient regulation of mtorc1 at the lysosome","volume":"156","author":"Menon","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1042\/BST20130041","article-title":"A\u00a0growing role for mTOR in promoting anabolic metabolism","volume":"41","author":"Howell","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ajcn\/77.1.43","article-title":"Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets","volume":"77","author":"Schwarz","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib36","first-page":"507","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2011.09.001","article-title":"Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c","volume":"14","author":"Wan","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","article-title":"Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways","volume":"14","author":"Yecies","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib39","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib41","doi-asserted-by":"crossref","first-page":"16184","DOI":"10.1073\/pnas.1213343109","article-title":"Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase","volume":"109","author":"Owen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib42","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1074\/jbc.274.42.30028","article-title":"Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus","volume":"274","author":"Shimomura","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmet.2011.12.017","article-title":"The Scap\/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals","volume":"15","author":"Moon","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib45","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1101\/gad.891301","article-title":"SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation","volume":"15","author":"Matsuda","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2011.07.019","article-title":"Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver","volume":"56","author":"Dentin","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib47","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1073\/pnas.0401516101","article-title":"Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis","volume":"101","author":"Iizuka","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib48","doi-asserted-by":"crossref","first-page":"E358","DOI":"10.1152\/ajpendo.00027.2006","article-title":"Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob\/ob) mice","volume":"291","author":"Iizuka","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib49","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI41636","article-title":"The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans","volume":"122","author":"Benhamed","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib50","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.bbalip.2011.07.016","article-title":"ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity","volume":"1811","author":"Hurtado Del Pozo","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib51","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.molmet.2017.07.006","article-title":"Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice","volume":"6","author":"Jois","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1194\/jlr.M081836","article-title":"Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice","volume":"59","author":"Linden","year":"2018","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib53","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jc.2015-3476","article-title":"Impaired insulin suppression of VLDL-triglyceride kinetics in nonalcoholic fatty liver disease","volume":"101","author":"Poulsen","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2337\/diab.42.6.833","article-title":"Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL ApoB production in normal weight and obese individuals","volume":"42","author":"Lewis","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/oby.2006.281","article-title":"Metabolic syndrome\u202f: focus on dyslipidemia","volume":"14","author":"Ginsberg","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1152\/ajpendo.1984.246.2.E187","article-title":"Hyperinsulinemia and in\u00a0vivo very-low-density lipoprotein-triglyceride kinetics","volume":"246","author":"Steiner","year":"1984","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib57","first-page":"1029","article-title":"Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice","volume":"119","author":"Han","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib58","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1172\/JCI96036","article-title":"MTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion","volume":"127","author":"Quinn","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib59","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11892-009-0034-5","article-title":"The role of FOXO in the regulation of metabolism","volume":"9","author":"Gross","year":"2008","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib60","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1074\/jbc.M600272200","article-title":"FoxO1 regulates multiple metabolic pathways in the liver effects on gluconeogenic, glycolytic, and lipogenic gene expression","volume":"281","author":"Zhang","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.celrep.2016.03.021","article-title":"Integrated regulation of hepatic lipid and glucose metabolism by ATGL and FoxO proteins","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib62","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/ncomms6190","article-title":"Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors","volume":"5","author":"Haeusler","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib63","doi-asserted-by":"crossref","first-page":"20132","DOI":"10.1074\/jbc.M112.347211","article-title":"FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c","volume":"287","author":"Deng","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib64","doi-asserted-by":"crossref","first-page":"32432","DOI":"10.1074\/jbc.M806179200","article-title":"A\u00a0combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding","volume":"283","author":"Hirota","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib65","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cell.2017.09.045","article-title":"Selective inhibition of FOXO1 activator\/repressor balance modulates hepatic glucose handling","volume":"171","author":"Langlet","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib66","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/db10-1032","article-title":"Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy","volume":"59","author":"Rizza","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib67","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cmet.2013.06.001","article-title":"A\u00a0noncanonical, GSK3-independent pathway controls postprandial hepatic glycogen deposition","volume":"18","author":"Wan","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib69","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.2337\/db13-0880","article-title":"Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis","volume":"62","author":"Von Wilamowitz-Moellendorff","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3945\/an.112.002089","article-title":"Regulation of hepatic glucose uptake and storage in\u00a0vivo","volume":"3","author":"Moore","year":"2012","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib71","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s001250051021","article-title":"The direct and indirect effects of insulin on hepatic glucose production in\u00a0vivo","volume":"41","author":"Cherrington","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib72","doi-asserted-by":"crossref","first-page":"e91863","DOI":"10.1172\/jci.insight.91863","article-title":"Insulin\u2019s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion","volume":"2","author":"Edgerton","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib73","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1042\/BST0351171","article-title":"Insulin action on the liver in\u00a0vivo","volume":"35","author":"Cherrington","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib74","doi-asserted-by":"crossref","first-page":"E718","DOI":"10.1152\/ajpendo.00156.2003","article-title":"Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice","volume":"285","author":"Altomonte","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib75","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","article-title":"Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver","volume":"6","author":"Matsumoto","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib76","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the regulation of hepatic metabolism by insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib77","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature11705","article-title":"Central nervous system control of metabolism","volume":"491","author":"Myers","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib78","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1113\/jphysiol.2009.179192","article-title":"Hormone and glucose signalling in POMC and AgRP neurons","volume":"587","author":"Belgardt","year":"2009","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib79","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cmet.2007.05.004","article-title":"Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production","volume":"5","author":"K\u00f6nner","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib80","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nature03439","article-title":"Hypothalamic KATP channels control hepatic glucose production","volume":"434","author":"Pocai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib81","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmet.2006.02.009","article-title":"Role of hepatic STAT3 in brain-insulin action on hepatic glucose production","volume":"3","author":"Inoue","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib82","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/nm1202-798","article-title":"Hypothalamic insulin signaling is required for inhibition of glucose production","volume":"8","author":"Obici","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib83","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm1201","article-title":"Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis","volume":"11","author":"Lam","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib85","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1152\/physrev.1996.76.4.1109","article-title":"Regulation of gene expression by insulin","volume":"76","author":"O\u2019Brien","year":"1996","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib86","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diabetes.48.5.1198","article-title":"Control of glucose uptake and release by the liver in\u00a0vivo","volume":"48","author":"Cherrington","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0026-0495(91)90194-2","article-title":"Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp","volume":"40","author":"Myers","year":"1991","journal-title":"Metabolism"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib88","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/jc.2017-01197","article-title":"Impaired insulin action is associated with increased glucagon concentrations in nondiabetic humans","volume":"103","author":"Sharma","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib89","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cmet.2009.02.007","article-title":"Insulin signaling in alpha cells modulates glucagon secretion in\u00a0vivo","volume":"9","author":"Kawamori","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib90","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/dom.12480","article-title":"Inhibiting or antagonizing glucagon: making progress in diabetes care","volume":"17","author":"Lef\u00e8bvre","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib91","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1172\/JCI119867","article-title":"Indirect effect of insulin to suppress endogeneous glucose production is dominant, even with hyperglucoagonemia","volume":"100","author":"Mittelman","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib92","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2337\/diab.44.9.1038","article-title":"Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin","volume":"44","author":"Rebrin","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib93","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/diab.46.2.187","article-title":"The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog","volume":"46","author":"Sindelar","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib94","doi-asserted-by":"crossref","first-page":"E402","DOI":"10.1152\/ajpendo.00136.2001","article-title":"Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs","volume":"282","author":"Chu","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib95","first-page":"745","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-1003285","article-title":"The effects of fasting and refeeding on liver glycogen synthase and phosphorylase in obese and lean mice","volume":"24","author":"Chen","year":"1992","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib97","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.10.016_bib98","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI27073","article-title":"Insulin\u2019 s direct effects on the liver dominate the control of hepatic glucose production","volume":"116","author":"Edgerton","year":"2006","journal-title":"J\u00a0Clin Invest"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X18301620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X18301620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:21:48Z","timestamp":1762453308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X18301620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["S2352345X18301620"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2018.10.016","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resolving the Paradox of Hepatic Insulin Resistance","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2018.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}